JP2021521165A5 - - Google Patents
Info
- Publication number
- JP2021521165A5 JP2021521165A5 JP2020555420A JP2020555420A JP2021521165A5 JP 2021521165 A5 JP2021521165 A5 JP 2021521165A5 JP 2020555420 A JP2020555420 A JP 2020555420A JP 2020555420 A JP2020555420 A JP 2020555420A JP 2021521165 A5 JP2021521165 A5 JP 2021521165A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- quinoline
- oxazepino
- chloro
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024082277A JP7855637B2 (ja) | 2018-04-13 | 2024-05-21 | Ｂｃｌ６阻害剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1806132.5 | 2018-04-13 | ||
| GBGB1806132.5A GB201806132D0 (en) | 2018-04-13 | 2018-04-13 | Inhibitor coumpounds |
| GBGB1819136.1A GB201819136D0 (en) | 2018-11-23 | 2018-11-23 | Inhibitor compounds |
| GB1819136.1 | 2018-11-23 | ||
| PCT/GB2019/051058 WO2019197842A1 (en) | 2018-04-13 | 2019-04-12 | Bcl6 inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024082277A Division JP7855637B2 (ja) | 2018-04-13 | 2024-05-21 | Ｂｃｌ６阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021521165A JP2021521165A (ja) | 2021-08-26 |
| JP2021521165A5 true JP2021521165A5 (OSRAM) | 2022-02-07 |
| JP7493454B2 JP7493454B2 (ja) | 2024-05-31 |
Family
ID=66240166
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555420A Active JP7493454B2 (ja) | 2018-04-13 | 2019-04-12 | Ｂｃｌ６阻害剤 |
| JP2024082277A Active JP7855637B2 (ja) | 2018-04-13 | 2024-05-21 | Ｂｃｌ６阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024082277A Active JP7855637B2 (ja) | 2018-04-13 | 2024-05-21 | Ｂｃｌ６阻害剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11512095B2 (OSRAM) |
| EP (3) | EP4729127A2 (OSRAM) |
| JP (2) | JP7493454B2 (OSRAM) |
| KR (2) | KR20250105504A (OSRAM) |
| CN (2) | CN112334475B (OSRAM) |
| AU (2) | AU2019253510B2 (OSRAM) |
| BR (1) | BR112020020832A2 (OSRAM) |
| CA (1) | CA3095371A1 (OSRAM) |
| DK (1) | DK3774817T3 (OSRAM) |
| ES (2) | ES2939776T3 (OSRAM) |
| HR (1) | HRP20230120T1 (OSRAM) |
| IL (2) | IL296734B2 (OSRAM) |
| MX (2) | MX2020010805A (OSRAM) |
| PT (1) | PT3774817T (OSRAM) |
| SG (1) | SG11202009735QA (OSRAM) |
| WO (1) | WO2019197842A1 (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019253510B2 (en) * | 2018-04-13 | 2023-08-10 | Cancer Research Technology Limited | BCL6 inhibitors |
| GB201909573D0 (en) | 2019-07-03 | 2019-08-14 | Cancer Research Tech Ltd | Modulation of T cell cytotoxicity and related therapy |
| GB201914860D0 (en) * | 2019-10-14 | 2019-11-27 | Cancer Research Tech Ltd | Inhibitor compounds |
| US12310975B2 (en) * | 2019-10-17 | 2025-05-27 | Arvinas Operations, Inc. | Modulators of BCL6 proteolysis and associated methods of use |
| CA3214806A1 (en) | 2021-04-16 | 2022-10-20 | Arvinas Operations, Inc. | Modulators of bcl6 proteolysis and associated methods of use |
| CR20250001A (es) | 2022-06-06 | 2025-05-14 | Treeline Biosciences Inc | Degradadores bifuncionales de bcl6 de quinolona tricíclica |
| JP2025525324A (ja) | 2022-06-13 | 2025-08-05 | ツリーライン バイオサイエンシズ インコーポレイテッド | １，８－ナフチリジン－２－オンヘテロ二官能性ｂｃｌ６分解剤 |
| AU2023292893A1 (en) | 2022-06-13 | 2025-01-02 | Treeline Biosciences, Inc. | Quinolone bcl6 bifunctional degraders |
| JP2025524835A (ja) * | 2022-07-19 | 2025-08-01 | ダナ－ファーバー キャンサー インスティテュート，インコーポレイテッド | キノキサリンジオンおよびピリド［２，３－ｂ］ピラジン－２，３－ジオンｂ細胞リンパ腫６（ｂｃｌ６）分解剤ならびにその使用 |
| CN120813582A (zh) * | 2023-03-17 | 2025-10-17 | 西藏海思科制药有限公司 | 一种含氮三并环衍生物及其在医药上的应用 |
| WO2025049964A1 (en) * | 2023-09-01 | 2025-03-06 | Treeline Biosciences, Inc. | Bcl6 bifunctional degraders |
| AU2024331309A1 (en) * | 2023-09-01 | 2026-03-19 | Treeline Biosciences, Inc. | Tricyclic quinolone bcl6 bifunctional degraders |
| CN120987969A (zh) * | 2024-05-21 | 2025-11-21 | 中国药科大学 | 一类蛋白靶向降解嵌合体及其用途 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0259572A (ja) | 1988-08-23 | 1990-02-28 | Mitsubishi Kasei Corp | ベンズイミダゾロン誘導体又はその塩類 |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| WO1997030035A1 (en) | 1996-02-13 | 1997-08-21 | Zeneca Limited | Quinazoline derivatives as vegf inhibitors |
| ES2169355T3 (es) | 1996-03-05 | 2002-07-01 | Astrazeneca Ab | Derivados de 4-anilinoquinazolina. |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| AU760250B2 (en) | 1998-12-04 | 2003-05-08 | Neurosearch A/S | New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| BRPI0017548B8 (pt) | 1999-02-10 | 2023-05-02 | Astrazeneca Ab | Composto |
| CZ2002233A3 (cs) | 1999-07-21 | 2002-04-17 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazolonové deriváty, způsob jejich výroby a farmaceutický prostředek |
| IL152682A0 (en) | 2000-05-31 | 2003-06-24 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| UA73993C2 (uk) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
| BR0112224A (pt) | 2000-07-07 | 2003-06-10 | Angiogene Pharm Ltd | Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto |
| HUP0301742A3 (en) | 2000-07-07 | 2005-08-29 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors, process for producing them, pharmaceutical compositions containing them and their use |
| UY27304A1 (es) | 2001-05-24 | 2002-12-31 | Avanir Pharmaceuticals | Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación |
| AU2003231231A1 (en) | 2002-05-06 | 2003-11-11 | Bayer Pharmaceuticals Corporation | Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders |
| US7825132B2 (en) | 2002-08-23 | 2010-11-02 | Novartis Vaccines And Diagnostics, Inc. | Inhibition of FGFR3 and treatment of multiple myeloma |
| US20050256157A1 (en) | 2002-08-23 | 2005-11-17 | Chiron Corporation | Combination therapy with CHK1 inhibitors |
| CA2656507C (en) | 2006-07-17 | 2012-03-20 | Amgen Inc. | Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| WO2008066887A2 (en) | 2006-11-30 | 2008-06-05 | Albert Einstein College Of Medicine Of Yeshiva University | Small molecule inhibitors of bcl6 |
| US8686008B2 (en) | 2007-08-16 | 2014-04-01 | The University Of Mississippi | Highly selective sigma receptor ligands |
| WO2009063240A1 (en) | 2007-11-16 | 2009-05-22 | Arrow Therapeutics Limited | 2,4-diaminopyrimidine derivatives useful as inhibitors of aurora kinase |
| US8071766B2 (en) | 2008-02-01 | 2011-12-06 | Takeda Pharmaceutical Company Limited | HSP90 inhibitors |
| EP2364983B1 (en) | 2008-11-11 | 2013-10-23 | Jeil Pharmaceutical Co., Ltd. | Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same |
| PL2389372T3 (pl) | 2009-01-23 | 2016-02-29 | Rigel Pharmaceuticals Inc | Kompozycje i sposoby hamowania szlaku JAK |
| EA201290642A1 (ru) | 2010-01-13 | 2013-05-30 | ГЛЭКСОСМИТКЛАЙН ЭлЭлСи | Соединения и способы |
| ES2698847T3 (es) | 2011-07-07 | 2019-02-06 | Merck Patent Gmbh | Azaheterociclos sustituidos para el tratamiento del cáncer |
| CA2877146C (en) | 2012-06-18 | 2020-10-20 | Dart Neuroscience (Cayman) Ltd | Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds |
| EP2964642B1 (en) | 2013-03-05 | 2017-11-15 | F. Hoffmann-La Roche AG | Inhibitors of bruton's tyrosine kinase |
| US9943506B2 (en) | 2013-06-17 | 2018-04-17 | Cornell University | BCL6 inhibitors as anticancer agents |
| CN105017159B (zh) | 2014-04-28 | 2019-05-17 | 四川大学 | 5-氟-2,4-二取代氨基嘧啶衍生物及其制备方法和用途 |
| ES2914099T3 (es) | 2014-08-25 | 2022-06-07 | Salk Inst For Biological Studi | Inhibidores novedosos de ULK1 y métodos de uso de los mismos |
| WO2016033416A1 (en) | 2014-08-29 | 2016-03-03 | Board Of Regents, University Of Texas System | Bromodomain inhibitors for treating disease |
| AU2015357498B2 (en) | 2014-12-06 | 2019-09-12 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2017007658A1 (en) | 2015-07-07 | 2017-01-12 | Rigel Pharmaceuticals, Inc. | A combination for immune mediated cancer treatment |
| JP6999688B2 (ja) * | 2016-12-13 | 2022-02-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｂｃｌ６阻害剤としての新規の６－アミノキノリノン化合物および誘導体 |
| AU2018274723B2 (en) | 2017-05-26 | 2024-01-18 | Cancer Research Technology Limited | Benzimidazolone derived inhibitors of BCL6 |
| US11161839B2 (en) | 2017-05-26 | 2021-11-02 | The Institute Of Cancer Research: Royal Cancer Hospital | 2-quinolone derived inhibitors of BCL6 |
| GB201819136D0 (en) | 2018-11-23 | 2019-01-09 | Cancer Research Tech Ltd | Inhibitor compounds |
| AU2019253510B2 (en) | 2018-04-13 | 2023-08-10 | Cancer Research Technology Limited | BCL6 inhibitors |
| GB201914860D0 (en) | 2019-10-14 | 2019-11-27 | Cancer Research Tech Ltd | Inhibitor compounds |
-
2019
- 2019-04-12 AU AU2019253510A patent/AU2019253510B2/en active Active
- 2019-04-12 EP EP25225215.0A patent/EP4729127A2/en active Pending
- 2019-04-12 WO PCT/GB2019/051058 patent/WO2019197842A1/en not_active Ceased
- 2019-04-12 KR KR1020257022060A patent/KR20250105504A/ko active Pending
- 2019-04-12 US US17/046,650 patent/US11512095B2/en active Active
- 2019-04-12 CA CA3095371A patent/CA3095371A1/en active Pending
- 2019-04-12 BR BR112020020832-9A patent/BR112020020832A2/pt active Search and Examination
- 2019-04-12 KR KR1020207032149A patent/KR102830237B1/ko active Active
- 2019-04-12 ES ES19718834T patent/ES2939776T3/es active Active
- 2019-04-12 CN CN201980039513.4A patent/CN112334475B/zh active Active
- 2019-04-12 PT PT197188345T patent/PT3774817T/pt unknown
- 2019-04-12 IL IL296734A patent/IL296734B2/en unknown
- 2019-04-12 SG SG11202009735QA patent/SG11202009735QA/en unknown
- 2019-04-12 EP EP22211485.2A patent/EP4201939B1/en active Active
- 2019-04-12 EP EP19718834.5A patent/EP3774817B1/en active Active
- 2019-04-12 ES ES22211485T patent/ES3060268T3/es active Active
- 2019-04-12 JP JP2020555420A patent/JP7493454B2/ja active Active
- 2019-04-12 CN CN202411445401.8A patent/CN119330979A/zh active Pending
- 2019-04-12 DK DK19718834.5T patent/DK3774817T3/da active
- 2019-04-12 HR HRP20230120TT patent/HRP20230120T1/hr unknown
- 2019-04-12 MX MX2020010805A patent/MX2020010805A/es unknown
-
2020
- 2020-10-04 IL IL277778A patent/IL277778B2/en unknown
- 2020-10-12 MX MX2023004920A patent/MX2023004920A/es unknown
-
2022
- 2022-10-18 US US17/968,159 patent/US12486285B2/en active Active
-
2023
- 2023-11-09 AU AU2023263501A patent/AU2023263501B2/en active Active
-
2024
- 2024-05-21 JP JP2024082277A patent/JP7855637B2/ja active Active
-
2025
- 2025-10-03 US US19/349,679 patent/US20260042776A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20230120T1 (hr) | Inhibitori bcl6 | |
| RU2473549C2 (ru) | Пиримидиновые соединения, композиции и способы применения | |
| JP2022504936A5 (OSRAM) | ||
| JP2024532735A (ja) | 複素環式化合物及び使用方法 | |
| US20240417412A1 (en) | Heterocyclic compounds and methods of use | |
| JP2025533831A (ja) | Ｋｒａｓ ｇ１２ｃ変異タンパク質のテザー型複素環式阻害剤及びその使用 | |
| AU2022265682A1 (en) | 2-aminobenzothiazole compounds and methods of use thereof | |
| AU2024266099A1 (en) | Spiro-heterocyclic inhibitors of kras g12c mutant proteins and uses thereof | |
| US20250163064A1 (en) | Quinazoline compounds and uses thereof as inhibitors of mutant kras proteins | |
| US9751881B2 (en) | Inhibitors of the renal outer medullary potassium channel | |
| JP2015521600A5 (OSRAM) | ||
| US10662203B2 (en) | Pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection | |
| JP2017222709A5 (OSRAM) | ||
| HRP20180080T1 (hr) | Pirimidopirimidinoni korisni kao inhibitori wee-1 kinaze | |
| JP2019535664A5 (OSRAM) | ||
| JP2015526395A5 (OSRAM) | ||
| RU2019115115A (ru) | Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7 | |
| JP2016518372A5 (OSRAM) | ||
| JP2011516558A5 (OSRAM) | ||
| JP2015526394A5 (OSRAM) | ||
| JP2011500774A5 (OSRAM) | ||
| JP2017531672A5 (OSRAM) | ||
| JP2022551950A5 (OSRAM) | ||
| JP2025538097A (ja) | がんを処置するための方法 | |
| JP2005519086A5 (OSRAM) |